VCEL

#2058
Vericel Corporation
35.1400 USD
+2.03%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
35.1400
35.1400
Rango anual
28.9500
43.0000
Cambio diario
+2.03%
Variación mensual
+7.17%
Variación en los últimos 6 meses
-3.33%
Cambio anual
-3.33%
Cierres anteriores
34.4400
Abrir
35.1400
Bid
Ask
Mínimo
35.1400
High
35.1400
Volumen
65
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 1.7838 B
  • Employee 398
  • Founded 1989
  • CEO Nick Colangelo
  • Website www.vcel.com
  • Headquarter Michigan, United States
  • FIGI BBG000BDCM24
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
112.53
Relación precio/flujo de caja
6.8

Vericel Corporation

Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan. In the spring of 2014, Aastrom Bio acquired Sanofi's cell therapy and regenerative medicine business which Sanofi had acquired when purchasing Genzyme in 2011. This transformed Aastrom in several ways: it increased the employee count by 8-fold and provided a revenue stream and products to market, which it had not had before. In October 2014, the company changed its name from Aastrom Bio to Vericel and relocated its headquarters from Ann Arbor, Michigan to Cambridge, Massachusetts.

Noticias